Publication | Closed Access
Response of Bladder Carcinoma Cells to TRAIL and Antisense Oligonucleotide, Bcl-2 or Clusterin Treatments
11
Citations
17
References
2009
Year
This study provides proof of principle that TRAIL combined with antisense oligonucleotide-Bcl-2 may have potential as a novel future treatment strategy for bladder transitional cell carcinoma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1